C12Y 201/01072
Site-specific dna-methyltransferase
Official title: Site-specific DNA-methyltransferase (adenine-specific) (2.1.1.72)
C12Y201/01072 (Site-specific dna-methyltransferase) appears on 17 US grants and 34 published applications in this corpus.
Search patents in C12Y- Granted patents
- 17
- Published applications
- 34
- Assignees
- 22
- Inventors
- 85
- Latest grant
- 7 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2009 | 0 | 1 |
| 2010 | 0 | 0 |
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 1 | 1 |
| 2014 | 0 | 2 |
| 2015 | 3 | 2 |
| 2016 | 1 | 2 |
| 2017 | 1 | 3 |
| 2018 | 1 | 0 |
| 2019 | 1 | 0 |
| 2020 | 2 | 1 |
| 2021 | 0 | 3 |
| 2022 | 1 | 3 |
| 2023 | 1 | 6 |
| 2024 | 1 | 3 |
| 2025 | 1 | 3 |
| 2026 | 3 | 3 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Compositions and methods for the targeting of PCSK97 Apr 2026US 12,594,349 B2Scribe Therapeutics Inc.
- Compositions and methods for the targeting of PCSK917 Feb 2026US 12,551,573 B2Scribe Therapeutics Inc.
- Modified CPG dinucleotides for recombinant viral vector production6 Jan 2026US 12,514,933 B2Siren Biotechnology, Inc.
- Programmable epigenetic control of gene expression in plants21 Jan 2025US 12,203,083 B2Decibel Bio, Inc
- Method of transforming photosynthetic organisms17 Dec 2024US 12,168,772 B2Viridos, Inc.
- Modified cpg dinucleotides for recombinant viral vector production28 May 2026US 2026/0144896 A1Siren Biotechnology, Inc.
- Compositions and methods for treating bacterial disease29 Jan 2026US 2026/0027191 A1Arizona Board of Regents on Behalf of the University of Arizona
- Detection of base modifications by enhancing electrical contrast in nanopores29 Jan 2026US 2026/0028668 A1Ramot at Tel-Aviv University Ltd.
- Enzyme composition with at least two different thermostable polypeptides having type ii dna methyltransferase activity6 Nov 2025US 2025/0340851 A1Blucon Biotech GmbH
- Modified cpg dinucleotides for recombinant viral vector production3 Apr 2025US 2025/0108130 A1Siren Biotechnology, Inc.
Most cited
By later US patents
- Polynucleotides encoding BREX system polypeptides and methods of using same10US 10,767,156 B2Yeda Research and Development Co. Ltd. · 2020
- Compositions and methods for gene editing7US 11,434,491 B2The Regents of the University of California · 2022
- Polypeptide targeting to mitochondria4US 9,139,628 B2Medical Research Council · 2015